CD4 and cancer: The positive correlation of the presence of EBV genetic material to the percentage of lymphocytes expressing PD-1 (i.e., CD4+ T lymphocytes in the blood and CD4+ and T CD8+ T cells in laryngeal cancer tissue and lymph nodes) may indicate a negative role for EBV in the process of anti-cancer defense.